Sphere-9 PAF China Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 180 participants.
Also called NCT07789925
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Registry
-
NCT07789925
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07789925. Allocation not applicable; no masking; primary purpose treatment. Start 2026-09-02 (anticipated); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sphere-9 PAF China Study
- Condition
- Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device)
- Catheter ablation using Sphere-9™ Catheter and Affera™ Integrated Mapping and Ablation System
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct07789925- Content hash
b7a8e417b953b3de9c8b8097b5c380d0bbae7331a036d0011a896d9f7c50e33b